«Overall there appears to be a benefit of a fifth course of cytarabine in low - risk patients with AML,» said Kelly D. Getz, PhD, of the Children's Hospital of Philadelphia, who presented the results. (cancernetwork.com)
Crook KI, Early PJ, Messenger KM, Muñana KR, Gallagher R, Papich MG: The pharmacokinetics of cytarabine in dogs when administered via subcutaneous and continuous intravenous infusion routes. (charlestonvrc.com)
This observation raises the possibility that treatment regimens for AML, such as high - dose cytarabine, may be beneficial in treating this deadly malignancy. (massgenomics.org)